Wide-area transepithelial sampling with 3-dimensional cytology: Does it detect more dysplasia or yield more hype?

Affiliations

¹ Department of Medicine, Division of Gastroenterology and Hepatology, Baltimore, Maryland, USA.
² Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

Editorial

Marcia Irene Canto et al. Gastrointest Endosc. 2018 Feb.

. 2018 Feb;87(2):356-359.

doi: 10.1016/j.gie.2017.11.005.

¹ Department of Medicine, Division of Gastroenterology and Hepatology, Baltimore, Maryland, USA.
² Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

No abstract available

Comment in

WATS for Barrett's surveillance.
Goldblum JR, Shaheen NJ, Vennalaganti PR, Sharma P, Lightdale CJ. Goldblum JR, et al. Gastrointest Endosc. 2018 Jul;88(1):201-202. doi: 10.1016/j.gie.2018.01.038. Gastrointest Endosc. 2018. PMID: 29935618 No abstract available.
Response.
Canto MI, Montgomery E. Canto MI, et al. Gastrointest Endosc. 2018 Jul;88(1):202-203. doi: 10.1016/j.gie.2018.03.006. Gastrointest Endosc. 2018. PMID: 29935619 No abstract available.

Increased detection of Barrett's esophagus-associated neoplasia using wide-area trans-epithelial sampling: a multicenter, prospective, randomized trial.
Vennalaganti PR, Kaul V, Wang KK, Falk GW, Shaheen NJ, Infantolino A, Johnson DA, Eisen G, Gerson LB, Smith MS, Iyer PG, Lightdale CJ, Schnoll-Sussman F, Gupta N, Gross SA, Abrams J, Haber GB, Chuttani R, Pleskow DK, Kothari S, Goldblum JR, Zhang Y, Sharma P. Vennalaganti PR, et al. Gastrointest Endosc. 2018 Feb;87(2):348-355. doi: 10.1016/j.gie.2017.07.039. Epub 2017 Jul 27. Gastrointest Endosc. 2018. PMID: 28757316 Clinical Trial.